Understanding the role of the cytoprotective transcription factor nuclear factor erythroid 2-related factor 2—lessons from evolution, the animal kingdom and rare progeroid syndromes
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
The cytoprotective transcriptor factor nuclear factor erythroid 2– related factor 2 (NRF2) is part of a complex regulatory network that responds to environmental cues. To better understand its role in a cluster of inflammatory and pro-oxidative burden of lifestyle diseases that accumulate with age, lessons can be learned from evolution, the animal kingdom and progeroid syndromes. When levels of oxygen increased in the atmosphere, mammals required ways to protect themselves from the metabolic toxicity that arose from the production of reactive oxygen species. The evolutionary origin of the NRF2–Kelch-like ECH-associated protein 1 (KEAP1) signalling pathway from primitive origins has been a prerequisite for a successful life on earth, with checkpoints in antioxidant gene expression, inflammation, detoxification and protein homoeostasis. Examples from the animal kingdom suggest that superior antioxidant defense mechanisms with enhanced NRF2 expression have been developed during evolution to protect animals during extreme environmental conditions, such as deep sea diving, hibernation and habitual hypoxia. The NRF2–KEAP1 signalling pathway is repressed in progeroid (accelerated ageing) syndromes and a cluster of burden of lifestyle disorders that accumulate with age. Compelling links exist between tissue hypoxia, senescence and a repressed NRF2 system. Effects of interventions that activate NRF2, including nutrients, and more potent (semi)synthetic NRF2 agonists on clinical outcomes are of major interest. Given the broad-ranging actions of NRF2, we need to better understand the mechanisms of activation, biological function and regulation of NRF2 and its inhibitor, KEAP1, in different clinical conditions to ensure that modulation of this thiol-based system will not result in major adverse effects. Lessons from evolution, the animal kingdom and conditions of accelerated ageing clarify a major role of a controlled NRF2–KEAP1 system in healthy ageing and well-being.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Afshin, A., Sur, P. J., Fay, K. A., Cornaby, L., Ferrara, G., Salama, J. S., Mullany, E. C., Abate, K. H., Abbafati, C., Abebe, Z., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)30041-8 · Cited by 5,811
The KEAP1-NRF2 system: a thiol-based sensor-effector apparatus for maintaining redox homeostasis
Yamamoto, M., Kensler, T. W., & Motohashi, H. (2018) · Physiological Reviews · doi:10.1152/physrev.00023.2017 · Cited by 1,968
Suppression of Aging in Mice by the Hormone Klotho
Kurosu, H., Yamamoto, M., Clark, J. D., Pastor, J. V., Nandi, A., Gurnani, P., McGuinness, O. P., Chikuda, H., Yamaguchi, M., Kawaguchi, H., et al. (2005) · Science · doi:10.1126/science.1112766 · Cited by 1,935
Ageing as a Risk Factor for Disease
Niccoli, T., & Partridge, L. (2012) · Current Biology · doi:10.1016/j.cub.2012.07.024 · Cited by 1,831 · cited 2×
“Diseases of ageing are influenced by mechanisms that show strong evolutionary conservation and contribute to cancer, CVD and neurodegenerative diseases [39].”
BackgroundAdipose Tissue Hypoxia in Obesity and Its Impact on Adipocytokine Dysregulation
Hosogai, N., Fukuhara, A., Oshima, K., Miyata, Y., Tanaka, S., Segawa, K., Furukawa, S., Tochino, Y., Komuro, R., Matsuda, M., et al. (2007) · Diabetes · doi:10.2337/db06-0911 · Cited by 1,257 · cited 1×
“Considering that the NRF2 system evolved as a protective mechanism against oxidative stress when the oceans released free oxygen [6], it is evident that tissue hypoxaemia is a feature of age-associated burden of lifestyle diseases such as CKD [45], diabetes [46], obesity [47], cancer [48] and depression [49].”
BackgroundBardoxolone Methyl and Kidney Function in CKD with Type 2 Diabetes
Pergola, P. E., Raskin, P., Toto, R. D., Meyer, C. J., Huff, J. W., Grossman, E. B., Krauth, M., Ruiz, S., Audhya, P., Christ-Schmidt, H., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105351 · Cited by 890 · cited 1×
“These renal protective effects were confirmed when BARD increased eGFR in a study (Trial to Determine the Effects of Bardoxolone Methyl on eGFR in Patients With Type 2 Diabetes and Chronic Kidney Disease) of type 2 diabetics with CKD Stage 3 [97].”
BackgroundSelf-citationEnhancement of the gut barrier integrity by a microbial metabolite through the Nrf2 pathway
Singh, R., Chandrashekharappa, S., Bodduluri, S. R., Baby, B. V., Hegde, B., Kotla, N. G., Hiwale, A. A., Saiyed, T., Patel, P., Vijay-Kumar, M., et al. (2019) · Nature Communications · doi:10.1038/s41467-018-07859-7 · Cited by 713
Onken, B., & Driscoll, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008758 · Cited by 671 · cited 1×
“elegans [29], a role for NRF2 as a pro-longevity signalling pathway across phyla is supported.”
BackgroundThe Role of Oxidative Stress and Hypoxia in Pancreatic Beta-Cell Dysfunction in Diabetes Mellitus
Gerber, P. A., & Rutter, G. A. (2017) · Antioxidants & Redox Signaling · doi:10.1089/ars.2016.6755 · Cited by 654 · cited 1×
“Considering that the NRF2 system evolved as a protective mechanism against oxidative stress when the oceans released free oxygen [6], it is evident that tissue hypoxaemia is a feature of age-associated burden of lifestyle diseases such as CKD [45], diabetes [46], obesity [47], cancer [48] and depression [49].”
BackgroundFructose-driven glycolysis supports anoxia resistance in the naked mole-rat
Park, T. J., Reznick, J., Peterson, B. L., Blass, G., Omerbašić, D., Bennett, N. C., Kuich, P. H. J. L., Zasada, C., Browe, B. M., Hamann, W., et al. (2017) · Science · doi:10.1126/science.aab3896 · Cited by 641 · cited 1×
“During evolution they adapted to severe constant hypoxia in underground burrows and can survive prolonged periods of anoxia due to fructose-driven glycolysis [20].”
BackgroundTranscription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach
Cuadrado, A., Manda, G., Hassan, A., Alcaraz, M. J., Barbas, C., Daiber, A., Ghezzi, P., León, R., López, M. G., Oliva, B., et al. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014753 · Cited by 632 · cited 3×
“It is used clinically for the treatment of psoriasis and multiple sclerosis [41], but since activation of NRF2 by DMF attenuated vitamin D3– induced vascular calcification in an in vivo mouse model [96], its role in the prevention of vascular stiffness deserves attention.”
BackgroundSKN-1/Nrf, stress responses, and aging in Caenorhabditis elegans
Blackwell, T. K., Steinbaugh, M. J., Hourihan, J. M., Ewald, C. Y., & Isik, M. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.06.008 · Cited by 622
Repression of the Antioxidant NRF2 Pathway in Premature Aging
Kubben, N., Zhang, W., Wang, L., Voss, T. C., Yang, J., Qu, J., Liu, G.-H., & Misteli, T. (2016) · Cell · doi:10.1016/j.cell.2016.05.017 · Cited by 489 · cited 1×
“[37] identified the NRF2 antioxidant pathway as a driving mechanism in HGPS and showed that trapping of NRF2 at the nuclear periphery by progerin recapitulated the ageing defects and that reactivation of NRF2 reversed the progerinassociated nuclear ageing defects [37].”
BackgroundPérez, V. I., Buffenstein, R., Masamsetti, V., Leonard, S., Salmon, A. B., Mele, J., Andziak, B., Yang, T., Edrey, Y., Friguet, B., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809620106 · Cited by 418 · cited 1×
“Whereas several mechanisms may contribute to the mole rats’ exceptional resilience and efficient breakdown and clearance of damaged proteins [24], increased expression of NRF2–KEAP1 was reported to be a major factor responsible for maintaining their damage control mechanisms [21].”
BackgroundAging, Cell Senescence, and Chronic Disease: Emerging Therapeutic Strategies
Tchkonia, T., & Kirkland, J. L. (2018) · JAMA · doi:10.1001/jama.2018.12440 · Cited by 302 · cited 2×
“Considering the physiological clustering of tissue hypoxia, senescence and a repressed NRF2– KEAP1 system, it would be of interest to study whether a combination of NRF2 agonists, senolytics [63] and drugs that reduce cortical renal hypoxemia, such as sodium glucose cotransporter 2 inhibitors [102], would have salubri…”
BackgroundHealthy aging diets other than the Mediterranean: A focus on the Okinawan diet
Willcox, D. C., Scapagnini, G., & Willcox, B. J. (2014) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2014.01.002 · Cited by 273 · cited 1×
“Not surprisingly, Sardinian and Okinawan diets are both rich in pickled foods that contain alkyl catechols [68].”
BackgroundHaring, B., Selvin, E., Liang, M., Coresh, J., Grams, M. E., Petruski-Ivleva, N., Steffen, L. M., & Rebholz, C. M. (2017) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2016.11.004 · Cited by 254
Senger, D. R., Li, D., Jaminet, S.-C., & Cao, S. (2016) · PLOS ONE · doi:10.1371/journal.pone.0148042 · Cited by 124 · cited 4×
“Alkyl catechols are known NRF2 agonists [43] and it can be hypothesized that NRF2 activation might be responsible, in part, for prolonged life expectancy in these populations.”
BackgroundInfluentialVolonte, D., Liu, Z., Musille, P. M., Stoppani, E., Wakabayashi, N., Di, Y.-P., Lisanti, M. P., Kensler, T. W., & Galbiati, F. (2013) · Molecular Biology of the Cell · doi:10.1091/mbc.e12-09-0666 · Cited by 119 · cited 1×
“NRF2 activity decreases with ageing in mice [30] and when the NRF2 gene is inhibited, this promotes stress-induced premature senescence [31].”
BackgroundNrf2 activity is lost in the spinal cord and its astrocytes of aged mice
Duan, W., Zhang, R., Guo, Y., Jiang, Y., Huang, Y., Jiang, H., & Li, C. (2009) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-009-9194-5 · Cited by 75 · cited 1×
“NRF2 activity decreases with ageing in mice [30] and when the NRF2 gene is inhibited, this promotes stress-induced premature senescence [31].”
BackgroundKeap1-Nrf2 signaling pathway confers resilience versus susceptibility to inescapable electric stress
Zhang, J.-C., Yao, W., Dong, C., Han, M., Shirayama, Y., & Hashimoto, K. (2018) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-017-0848-0 · Cited by 66
Cited by
Chronic Inflammation in Chronic Kidney Disease Progression: Role of Nrf2
Stenvinkel, P., Chertow, G. M., Devarajan, P., Levin, A., Andreoli, S. P., Bangalore, S., & Warady, B. A. (2021) · Kidney International Reports · doi:10.1016/j.ekir.2021.04.023 · Cited by 297
Self-citationFood as medicine: targeting the uraemic phenotype in chronic kidney disease
Mafra, D., Borges, N. A., Lindholm, B., Shiels, P. G., Evenepoel, P., & Stenvinkel, P. (2021) · Nature Reviews Nephrology · doi:10.1038/s41581-020-00345-8 · Cited by 238
Self-citationStenvinkel, P., Shiels, P. G., & Johnson, R. J. (2023) · Journal of Environmental Management · doi:10.1016/j.jenvman.2022.116981 · Cited by 14
Self-citationFermented food: Should patients with cardiometabolic diseases go back to an early neolithic diet?
Mafra, D., Borges, N. A., Alvarenga, L., Ribeiro, M., Fonseca, L., Leal, V. O., Shiels, P. G., & Stenvinkel, P. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2077300 · Cited by 13
“These effects are mitigated or prevented by the action of the cytoprotective transcription factor Nrf2, which is responsible for activation of >300 antioxidant and cytoprotective genes (Abed et al. 2015; Checa and Aran 2020; Stenvinkel et al., 2020).”
BackgroundSelf-citationDai, L., Schurgers, L., Shiels, P. G., & Stenvinkel, P. (2021) · Clinical Science · doi:10.1042/cs20201452 · Cited by 11
Self-citation
Metadata
- Authors
- Stenvinkel, P., Meyer, C. J., Block, G. A., Chertow, G. M., & Shiels, P. G.
- Venue
- Nephrology Dialysis Transplantation
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-07-13
- Volume
- 35
- Issue
- 12
- Pages
- 2036-2045
- ISSN
- 0931-0509 (ISSN-L)
- 1460-2385
- OpenAlex
- W2961829627
- Cited by
- 72
- References
- 21
- FWCI
- 3.51
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.